Acasti Pharma (ACST) 10-K2024 FY Annual report

Filed: 21 Jun 24, 7:30am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: Abbvie, accredited, agent, Agriculture, AIGH, AKBM, analyzing, animal, ANSUSHRA, ArcLight, articulated, Ave, Avenue, Baltimore, bankrupt, Bartolomei, behavior, bench, Berkeley, bioresearch, bipartisan, bound, Brio, Carnegie, cGCP, Charlotte, chemical, clarification, clawback, CM, Codification, compensatory, compliant, compound, convene, credible, criterion, CRL, DelAversano, dispense, donut, du, dysphagic, Edward, excuse, expediting, FINRA, Francisco, gap, gather, George, GLP, Grantor, guide, Hirschman, hole, hosted, hypothesized, identical, identity, inferred, insert, Inspector, Internet, invoking, ischemic, Justice, Kentucky, landscape, Ledgemont, mandatory, Meyer, moiety, mortality, multiplied, NC, NCE, Neose, Neugeboren, Neugebroren, neuro, notably, occasionally, official, OncoSec, organizational, Orin, outlining, overlap, oversaw, overseen, parallel, parent, Pearl, Pennsylvania, PFO, pharmacologic, pharmacological, piece, plc, Poplar, poverty, Princeton, procured, prorated, Pucciarelli, purity, QuadView, quantifiable, quantify, recall, recoupment, redemption, regenerative, Registraire, reorganization, repealing, revoke, Rider, Ridge, RLD, roadmap, Robert, robust, safeguarding, SD, sequential, signatory, Solvay, speaking, SS, steady, Steven, streamlining, Strongbridge, subdivided, sue, survey, sweeping, tasked, Tengion, therewith, thousand, threat, tied, Trenton, Trump, trustee, Tryon, unacceptable, unapproved, unclear, Unimed, unusual, user, vendor, Verrica, version, wait, week, Welfare, XyloCor

Removed: accrual, altogether, amortization, analyst, Antartic, assumed, attacked, automatically, avoid, behaviour, boul, Carter, categorized, chartered, classification, compelled, compensate, Concorde, continuously, delisting, delivering, denominated, derivation, device, disappoint, East, English, entirety, epidemic, Espace, euro, existed, factor, float, fluctuation, forma, France, functionality, historic, immaterial, impairing, inventory, invest, la, lab, Laval, lawsuit, lessening, leverage, maintained, merged, minimize, modification, nullification, Ontario, opposite, opposition, outbreak, pandemic, paper, profit, promissory, prospectively, pursued, realised, reclassified, released, rendered, representing, reserve, resolved, responding, RKO, separately, servicing, subtracting, summarize, sustained, systematic, translated, TRILOGY, unforeseen, unlimited, weaken, weakening

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

ACST similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

SECTION 906 CERTIFICATION

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) in connection with the Annual Report on Form 10-K of Acasti Pharma Inc. for the annual period ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned officer hereby certifies, to such officer’s knowledge, that:


(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Acasti Pharma Inc.


/s/ Robert DelAversano
Name:	Robert DelAversano
Title:	Principal Financial Officer
Date:	June 21, 2024

This certification accompanies the Report pursuant to §906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed “filed” by Acasti Pharma Inc. for purposes of §18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section.